435 related articles for article (PubMed ID: 24975604)
1. Tankyrases: structure, function and therapeutic implications in cancer.
Haikarainen T; Krauss S; Lehtio L
Curr Pharm Des; 2014; 20(41):6472-88. PubMed ID: 24975604
[TBL] [Abstract][Full Text] [Related]
2. Tankyrases as drug targets.
Lehtiö L; Chi NW; Krauss S
FEBS J; 2013 Aug; 280(15):3576-93. PubMed ID: 23648170
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for tankyrase-RNF146 interaction reveals noncanonical tankyrase-binding motifs.
DaRosa PA; Klevit RE; Xu W
Protein Sci; 2018 Jun; 27(6):1057-1067. PubMed ID: 29604130
[TBL] [Abstract][Full Text] [Related]
4. Poly-ADP ribosylation of p21 by tankyrases promotes p21 degradation and regulates cell cycle progression.
Jung M; Kim W; Cho JW; Yang WH; Chung IK
Biochem J; 2022 Nov; 479(22):2379-2394. PubMed ID: 36383218
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin ligase RNF146 regulates tankyrase and Axin to promote Wnt signaling.
Callow MG; Tran H; Phu L; Lau T; Lee J; Sandoval WN; Liu PS; Bheddah S; Tao J; Lill JR; Hongo JA; Davis D; Kirkpatrick DS; Polakis P; Costa M
PLoS One; 2011; 6(7):e22595. PubMed ID: 21799911
[TBL] [Abstract][Full Text] [Related]
6. A FRET-based high-throughput screening platform for the discovery of chemical probes targeting the scaffolding functions of human tankyrases.
Sowa ST; Vela-Rodríguez C; Galera-Prat A; Cázares-Olivera M; Prunskaite-Hyyryläinen R; Ignatev A; Lehtiö L
Sci Rep; 2020 Jul; 10(1):12357. PubMed ID: 32704068
[TBL] [Abstract][Full Text] [Related]
7. Regulation of tankyrase activity by a catalytic domain dimer interface.
Fan C; Yarravarapu N; Chen H; Kulak O; Dasari P; Herbert J; Yamaguchi K; Lum L; Zhang X
Biochem Biophys Res Commun; 2018 Sep; 503(3):1780-1785. PubMed ID: 30055800
[TBL] [Abstract][Full Text] [Related]
8. Tankyrase inhibitors as therapeutic targets for cancer.
Kamal A; Riyaz S; Srivastava AK; Rahim A
Curr Top Med Chem; 2014; 14(17):1967-76. PubMed ID: 25262803
[TBL] [Abstract][Full Text] [Related]
9. Discovery of potent and selective nonplanar tankyrase inhibiting nicotinamide mimics.
Nkizinkiko Y; Suneel Kumar BVS; Jeankumar VU; Haikarainen T; Koivunen J; Madhuri C; Yogeeswari P; Venkannagari H; Obaji E; Pihlajaniemi T; Sriram D; Lehtiö L
Bioorg Med Chem; 2015 Aug; 23(15):4139-4149. PubMed ID: 26183543
[TBL] [Abstract][Full Text] [Related]
10. An Evolutionary Perspective on the Origin, Conservation and Binding Partner Acquisition of Tankyrases.
Sowa ST; Bosetti C; Galera-Prat A; Johnson MS; Lehtiö L
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421702
[TBL] [Abstract][Full Text] [Related]
11. USP25 regulates Wnt signaling by controlling the stability of tankyrases.
Xu D; Liu J; Fu T; Shan B; Qian L; Pan L; Yuan J
Genes Dev; 2017 May; 31(10):1024-1035. PubMed ID: 28619731
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding.
Mariotti L; Pollock K; Guettler S
Br J Pharmacol; 2017 Dec; 174(24):4611-4636. PubMed ID: 28910490
[TBL] [Abstract][Full Text] [Related]
13. Allosteric activation of the RNF146 ubiquitin ligase by a poly(ADP-ribosyl)ation signal.
DaRosa PA; Wang Z; Jiang X; Pruneda JN; Cong F; Klevit RE; Xu W
Nature; 2015 Jan; 517(7533):223-6. PubMed ID: 25327252
[TBL] [Abstract][Full Text] [Related]
14. Identifying and Validating Tankyrase Binders and Substrates: A Candidate Approach.
Pollock K; Ranes M; Collins I; Guettler S
Methods Mol Biol; 2017; 1608():445-473. PubMed ID: 28695526
[TBL] [Abstract][Full Text] [Related]
15. Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer.
Yu M; Yang Y; Sykes M; Wang S
J Med Chem; 2022 Apr; 65(7):5244-5273. PubMed ID: 35306814
[TBL] [Abstract][Full Text] [Related]
16. Zinc binding catalytic domain of human tankyrase 1.
Lehtiö L; Collins R; van den Berg S; Johansson A; Dahlgren LG; Hammarström M; Helleday T; Holmberg-Schiavone L; Karlberg T; Weigelt J
J Mol Biol; 2008 May; 379(1):136-45. PubMed ID: 18436240
[TBL] [Abstract][Full Text] [Related]
17. Tankyrase as a Novel Molecular Target in Cancer and Fibrotic Diseases.
Lakshmi TV; Bale S; Khurana A; Godugu C
Curr Drug Targets; 2017; 18(10):1214-1224. PubMed ID: 27425647
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into SAM domain-mediated tankyrase oligomerization.
DaRosa PA; Ovchinnikov S; Xu W; Klevit RE
Protein Sci; 2016 Sep; 25(9):1744-52. PubMed ID: 27328430
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of the poly(ADP-ribose) polymerase activity of tankyrase 1, a potential regulator of telomere length.
Rippmann JF; Damm K; Schnapp A
J Mol Biol; 2002 Oct; 323(2):217-24. PubMed ID: 12381316
[TBL] [Abstract][Full Text] [Related]
20. Functional subdomain in the ankyrin domain of tankyrase 1 required for poly(ADP-ribosyl)ation of TRF1 and telomere elongation.
Seimiya H; Muramatsu Y; Smith S; Tsuruo T
Mol Cell Biol; 2004 Mar; 24(5):1944-55. PubMed ID: 14966275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
